Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
Relating to hospital patients' rights and hospital policies and procedures; providing an administrative penalty.
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.
Relating to patients' rights, consumer protection, and directives for the provision of health care services; providing an administrative penalty.
Relating to the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for use by patients as the best available medical treatment, the licensing of medical cannabis dispensing organizations, and the registration of certain individuals; authorizing fees.